Pharming Group N.V (PHARM) | Stock Overview & Key Data
Pharming Group N.V Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €459.55 on July 10, 2000
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pharming Group N.V
PHARM
|
1.02B Large-cap | 0.00% | 0.00% | -21.28% | -21.28% | -21.28% | -21.83% | -21.83% | -21.83% | -21.83% | -21.83% | -21.83% |
|
Galapagos NV
GLPGA
|
1.63B Large-cap | 1.96% | 6.58% | -12.43% | -6.24% | -11.43% | -1.66% | -35.89% | -60.48% | -44.69% | 414.23% | 177.11% |
|
Vivoryon
VVY
|
37.02M Small-cap | -8.06% | -8.80% | -16.79% | -24.50% | -21.38% | -29.88% | -91.69% | -93.20% | -93.99% | -94.14% | -94.14% |
|
Koninklijke Philips
PHIA
|
22.16B Large-cap | 2.76% | 5.68% | -1.37% | -1.37% | -1.37% | -2.85% | -2.85% | -2.85% | -2.85% | -2.85% | -2.85% |
|
ASML Holding N.V
ASML
|
481.62B Large-cap | 7.10% | 24.15% | 45.88% | 45.88% | 45.88% | 42.15% | 42.15% | 42.15% | 42.15% | 42.15% | 42.15% |
|
Shell plc
SHELL
|
212.61B Large-cap | -4.73% | -2.51% | -12.81% | -12.81% | -12.81% | -7.07% | -7.07% | -7.07% | -7.07% | -7.07% | -7.07% |
Ownership & Short Interest
Calculate Your Pharming Group N.V Investment Returns
Long-Term Investment Performance Analysis
Pharming Group N.V stock price in Mar 2026 was €1.42, A €1,000.00 lump sum investment in Pharming Group N.V made 0 years ago would be worth approximately €781.69 today, representing a negative return of -21.83%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is PHARM's 52-week high and low?
- In the last 52 weeks, Pharming Group N.V reached a high of €1.82 (on January 28, 2026) and a low of €0.84 (on N/A).
- What is the market cap and P/E ratio for PHARM?
- Curious about Pharming Group N.V's size and valuation? Its market capitalization stands at 1.02B. When it comes to valuation, the P/E ratio (trailing twelve months) is 57.15, and the forward P/E (looking ahead) is 46.77.
- Does PHARM pay dividends? If so, what's the yield?
- As for dividends, Pharming Group N.V isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Pharming Group N.V's main competitors or similar companies to consider before investing?
When looking at Pharming Group N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Galapagos NV
GLPGA1.63B Healthcare Biotechnology -1.66% -35.89% Vivoryon
VVY37.02M Healthcare Biotechnology -29.88% -91.69% Koninklijke Philips
PHIA22.16B Healthcare Medical Devices -2.85% -2.85% ASML Holding N.V
ASML481.62B Technology Semiconductor Equipment & Materials 42.15% 42.15% Shell plc
SHELL212.61B Energy Oil & Gas Integrated -7.07% -7.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Pharming Group N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Pharming Group N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.02%, the Debt to Equity ratio from the most recent quarter is 41.78, and its Gross Profit Margin stands at 80.19%.
- What is the recent revenue and earnings growth for PHARM?
- Looking at Pharming Group N.V's growth, its revenue over the trailing twelve months (TTM) was €321M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.00%, and quarterly earnings saw a YoY growth of 86.40%.
- How much of PHARM stock is held by insiders and institutions?
- Wondering who owns Pharming Group N.V stock? Company insiders (like executives and directors) hold about 1.89% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 20.99%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.